JOHN M SLOAN

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology BOSTON, MA NPI 1659345320

General Payments — all program years on this page

$262,458.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 122
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $18,395.46 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $16,187.503
Travel and Lodging $1,314.083
Food and Beverage $893.8810

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ADC Therapeutics America, Inc. $13,220.8612
Invivyd Inc $2,625.001
NOVARTIS PHARMACEUTICALS CORPORATION $2,362.501
ABBVIE INC. $110.471
Kyowa Kirin, Inc. $76.631

By program year

Program yearAmountRecords
2018 $7,829.964
2019 $37,602.3317
2020 $74,276.7517
2021 $35,644.6813
2022 $62,125.7333
2023 $26,583.4022
2024 $18,395.4616

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087328643 Novartis Pharmaceuticals Corporation $2,362.50 06/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1106119386 ABBVIE INC. $110.47 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188874 ADC Therapeutics America, Inc. $53.03 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188888 ADC Therapeutics America, Inc. $35.79 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188928 ADC Therapeutics America, Inc. $150.00 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188944 ADC Therapeutics America, Inc. $322.94 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1121188946 ADC Therapeutics America, Inc. $140.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188948 ADC Therapeutics America, Inc. $72.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188950 ADC Therapeutics America, Inc. $40.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188952 ADC Therapeutics America, Inc. $100.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188954 ADC Therapeutics America, Inc. $115.96 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121188956 ADC Therapeutics America, Inc. $256.56 12/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1121188958 ADC Therapeutics America, Inc. $734.58 09/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1121188962 ADC Therapeutics America, Inc. $11,200.00 10/31/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1127033069 Kyowa Kirin, Inc. $76.63 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147384597 Invivyd Inc $2,625.00 12/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.